| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.096 | 0.03 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.08 | 0.08 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.037 | 0.4 |